| Financial Year |
March 31 2023 |
| Monetary Funds |
63,756,333.71 |
| Held-for-trading Financial Assets |
137,337,923.84 |
| Notes Receivable |
-- |
| Accounts Receivable |
755,964.23 |
| Advances to Suppliers |
6,275,977.43 |
| Other Receivables |
332,751.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,700,582.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,297,267.61 |
| Total Current Assets |
223,456,800.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
616,875,046.48 |
| Investment Properties |
-- |
| Fixed Assetes |
16,025,945.11 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,665,087.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
184,381.29 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
31,057,684.93 |
| Sub-Total of Non-Current Assets |
675,949,007.01 |
| Total Assets |
899,405,807.80 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
641,845.13 |
| Accounts Received In Advance |
22,222.19 |
| Employee Compensation Payable |
1,119,688.73 |
| Taxes Payable |
104,655.59 |
| Interest Payable |
-- |
| Dividend Payable |
16,871,890.55 |
| Other payables |
17,692,956.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
925,646.68 |
| Other Current Liabilities |
90,348.10 |
| Sub-Total of Current Liabilities |
21,292,454.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
33,561.79 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,784,507.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,372,667.83 |
| Total Liabilities |
42,665,122.27 |
| Paid-In Capital(Or Share Stock) |
236,088,000.00 |
| Capital Surplus |
35,380,432.17 |
| Surplus Reserve |
83,741,128.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
415,452,491.71 |
| Minority Stockholder's Interest |
7,639,671.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
849,101,013.94 |
| Owner's Equity（Stockholder's Equity） |
856,740,685.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
899,405,807.80 |
